This market holds much potential as wel...
Novo Nordisk To Invest In Obesity Research With New Unit
This market holds much potential as well as risk. The recognition of obesity as a chronic disease will aid the efforts of pharmaceutical companies and Novo Nordisk will benefit from its expertise in diabetes, another chronic disease. Investment could lead to a portfolio of treatments, but success will depend upon further acceptance of this as a disease, acceptable safety risks, and increased payer/physician interest....Read article
Canal Development To Drive Public Unrest
Nicaragua's inter-oceanic canal project will prompt a deterioration in the country's political risk profile as it moves toward the first phase of construction. While we do not believe that the canal will be completed, initial development efforts will engender significant local unrest as the unfavour...Read article